Chronic granulomatous disease as a risk factor for autoimmune disease

Overview of attention for article published in The Journal of Allergy and Clinical Immunology, September 2008

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 1 X user

patent: 2 patents

Citations

dimensions_citation: 188 Dimensions

Readers on

mendeley: 106 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

PPAR AGONIST OR LXR AGONIST FOR USE IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS BY…

Application WO-2017182981-A1

World Intellectual Property Organisation (WIPO)

QUINOLINONE DERIVATIVES FOR USE IN THE TREATMENT OF AN AUTOIMMUNE DISEASE AND/OR AN…

Application WO-2012127214-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.